Gossypol Increases Expression of the Pro-apoptotic BH3-only Protein NOXA through a Novel Mechanism Involving Phospholipase A2, Cytoplasmic Calcium, and Endoplasmic Reticulum Stress
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Gossypol Increases Expression of the Pro-apoptotic BH3-only Protein NOXA through a Novel Mechanism Involving Phospholipase A2, Cytoplasmic Calcium, and Endoplasmic Reticulum Stress
Authors
Keywords
-
Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 289, Issue 23, Pages 16190-16199
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)
Online
2014-04-29
DOI
10.1074/jbc.m114.562900
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The putative BH3 mimetic S1 sensitizes leukemia to ABT-737 by increasing reactive oxygen species, inducing endoplasmic reticulum stress, and upregulating the BH3-only protein NOXA
- (2013) Ryan Soderquist et al. APOPTOSIS
- Gossypol suppresses mouse T lymphocytes via inhibition of NFκB, NFAT and AP-1 pathways
- (2013) Bocui Song et al. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- Bcl-2 antagonists: a proof of concept for CLL therapy
- (2013) Kumudha Balakrishnan et al. INVESTIGATIONAL NEW DRUGS
- Gossypol overcomes stroma-mediated resistance to the BCL2 inhibitor ABT-737 in chronic lymphocytic leukemia cells ex vivo
- (2013) R Soderquist et al. LEUKEMIA
- Natural Bcl-2 inhibitor (−)– gossypol induces protective autophagy via reactive oxygen species–high mobility group box 1 pathway in Burkitt lymphoma
- (2013) Zhenhong Ni et al. LEUKEMIA & LYMPHOMA
- Gossypol induces apoptosis in ovarian cancer cells through oxidative stress
- (2013) Jia Wang et al. Molecular BioSystems
- ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
- (2013) Andrew J Souers et al. NATURE MEDICINE
- Reactive oxygen species-mediated endoplasmic reticulum stress contributes to aldosterone-induced apoptosis in tubular epithelial cells
- (2012) Wei Ding et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The BH3 mimetic S1 induces autophagy through ER stress and disruption of Bcl-2/Beclin 1 interaction in human glioma U251 cells
- (2012) Jia-teng Zhong et al. CANCER LETTERS
- Gossypol Interferes with Both Type I and Type II Topoisomerase Activities Without Generating Strand Breaks
- (2012) Muge Senarisoy et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- Simultaneous activation of p38 and JNK by arachidonic acid stimulates the cytosolic phospholipase A2-dependent synthesis of lipid droplets in human monocytes
- (2012) Carlos Guijas et al. JOURNAL OF LIPID RESEARCH
- MAP-Kinase Regulated Cytosolic Phospholipase A2 Activity Is Essential for Production of Infectious Hepatitis C Virus Particles
- (2012) Nicolas Menzel et al. PLoS Pathogens
- Vinblastine sensitizes leukemia cells to cyclin-dependent kinase inhibitors, inducing acute cell cycle phase-independent apoptosis
- (2011) Darcy J.P. Bates et al. CANCER BIOLOGY & THERAPY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Multiple BH3 Mimetics Antagonize Antiapoptotic MCL1 Protein by Inducing the Endoplasmic Reticulum Stress Response and Up-regulating BH3-only Protein NOXA
- (2011) Tina C. Albershardt et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Phase I Study of Navitoclax (ABT-263), a Novel Bcl-2 Family Inhibitor, in Patients With Small-Cell Lung Cancer and Other Solid Tumors
- (2011) Leena Gandhi et al. JOURNAL OF CLINICAL ONCOLOGY
- Substantial Susceptibility of Chronic Lymphocytic Leukemia to BCL2 Inhibition: Results of a Phase I Study of Navitoclax in Patients With Relapsed or Refractory Disease
- (2011) Andrew W. Roberts et al. JOURNAL OF CLINICAL ONCOLOGY
- Oxidative stress caused by mitochondrial calcium overload
- (2010) Tsung-I Peng et al. Annals of the New York Academy of Sciences
- Acquired resistance to ABT-737 in lymphoma cells that up-regulate MCL-1 and BFL-1
- (2010) D. Yecies et al. BLOOD
- Gossypol Induces Death Receptor-5 through Activation of the ROS-ERK-CHOP Pathway and Sensitizes Colon Cancer Cells to TRAIL
- (2010) Bokyung Sung et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Vinblastine Induces Acute, Cell Cycle Phase–Independent Apoptosis in Some Leukemias and Lymphomas and Can Induce Acute Apoptosis in Others when Mcl-1 Is Suppressed
- (2010) Bethany L. Salerni et al. MOLECULAR CANCER THERAPEUTICS
- Endofacial competitive inhibition of the glucose transporter 1 activity by gossypol
- (2009) Alejandra Pérez et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- An Open-Label, Multicenter, Phase I/II Study of Single-Agent AT-101 in Men with Castrate-Resistant Prostate Cancer
- (2009) G. Liu et al. CLINICAL CANCER RESEARCH
- The (+)- and (−)-gossypols potently inhibit both 3β-hydroxysteroid dehydrogenase and 17β-hydroxysteroid dehydrogenase 3 in human and rat testes
- (2009) Guo-Xin Hu et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- ERAD inhibitors integrate ER stress with an epigenetic mechanism to activate BH3-only protein NOXA in cancer cells
- (2009) Q. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- AT-101, a small molecule inhibitor of anti-apoptotic Bcl-2 family members, activates the SAPK/JNK pathway and enhances radiation-induced apoptosis
- (2009) Shuraila F Zerp et al. Radiation Oncology
- Gossypol suppresses telomerase activity in human leukemia cells via regulating hTERT
- (2008) Dong-Oh Moon et al. FEBS LETTERS
- Mechanisms of the lysophosphatidic acid-induced increase in [Ca2+]i in skeletal muscle cells
- (2008) Yan-Jun Xu et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Phospholipase A2structure/function, mechanism, and signaling
- (2008) John E. Burke et al. JOURNAL OF LIPID RESEARCH
- Natural BH3 mimetic (-)-gossypol chemosensitizes human prostate cancer via Bcl-xL inhibition accompanied by increase of Puma and Noxa
- (2008) Y. Meng et al. MOLECULAR CANCER THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started